กำลังโหลด
NYSEHealthcareMedical - Instruments & Supplies
ข้อมูลล่าสุด
US$230.05
+US$3.32 · +1.46%
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
ราคาปิดก่อนหน้า
US$230.05
+US$3.32 · +1.46%
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
ช่วงราคารายวัน
ปัจจุบัน US$230.05
ช่วง 52 สัปดาห์
ปัจจุบัน US$230.05
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
คะแนน GoAI
ซื้อ
มูลค่า
99
มูลค่าน่าสนใจมาก
ความเชื่อมั่น
72
เชิงบวก
ความเสี่ยง
43
ความเสี่ยงค่อนข้างสูง
โมเมนตัม
40
กำลังอ่อนตัว
งานวิจัย GoAI ฉบับเต็ม
ดูข้อมูลสนับสนุน ปัจจัยหนุน และความเสี่ยงในเชิงลึก
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
ช่วงราคารายวัน
ปัจจุบัน US$230.05
ช่วง 52 สัปดาห์
ปัจจุบัน US$230.05
ผลประกอบการล่าสุดที่ประกาศ
ผลประกอบการล่าสุดที่ประกาศ
ประมาณการของนักวิเคราะห์ภายนอกอาจเปลี่ยนแปลงและไม่ใช่คำแนะนำของ GoAI
เป้าหมายเฉลี่ย
US$242.7
โอกาสปรับขึ้น 5.50%| รายการ | วันที่มีผลบังคับใช้ | รายละเอียด | วันกำหนดรายชื่อ | วันจ่ายเงิน |
|---|---|---|---|---|
การแยกหุ้น | 31 ส.ค. 2553 | 2:1 | — | — |
การแยกหุ้น | 3 ต.ค. 2548 | 2:1 | — | — |
การแยกหุ้น | 3 เม.ย. 2543 | 2:1 | — | — |
การแยกหุ้น | 17 พ.ย. 2541 | 2:1 | — | — |
มีผลแล้ว 31 ส.ค. 2553
2:1
มีผลแล้ว 3 ต.ค. 2548
2:1
มีผลแล้ว 3 เม.ย. 2543
2:1
มีผลแล้ว 17 พ.ย. 2541
2:1
กองทุนซื้อขายแลกเปลี่ยนที่รายงานความเสี่ยงต่อหุ้นนี้
State Street SPDR S&P 500 ETF1557.T63.19B0.05%129.35T JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI1.11B0.05%2.3T USD0.03%US$381.94+0.63%
Vanguard S&P 500 ETFVOO925.27M0.05%1.8T USD0.03%US$715.59+0.61%
Vanguard Morningstar Mid-Cap ETFVO753.35M0.33%226.4B USD0.03%US$81.14+0.92%
Vanguard Morningstar Growth ETFVUG444.29M0.12%384.6B USD0.03%US$91.97+0.72%
iShares Core S&P 500 ETFIVV434.85M0.05%896.44B USD0.03%US$781.97+0.60%
State Street SPDR S&P 500 ETFSPY399.21M0.05%817.2B USD0.09%US$778.57+0.60%
First Trust Rising Dividend Achievers ETFRDVY378.44M1.49%25.47B USD0.47%US$79.58+0.19%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Mid-Cap ETFVOVanguard Morningstar Growth ETFVUGiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYFirst Trust Rising Dividend Achievers ETFRDVYเนื้อหาที่สร้างโดย AI และข้อมูลตลาดที่ล่าช้ามีไว้เพื่อให้ข้อมูลและการศึกษาเท่านั้น ไม่ใช่คำแนะนำการลงทุน
